Fredun Pharmaceuticals fundamental analysis

FREDUN

2108

64.10 (3.14%)
Last updated on 22 Apr, 2026 | 15:29 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Fredun Pharmaceuticals Fundamentals

P/E Ratio

34.48

P/B Ratio

4.23

Div. Yield

0.03

Sector P/E

63.84

Sector P/B

3.48

Sec. Div. Yield

0.57

Fredun Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 34.48, compared to the sector average of 63.84. Its P/B Ratio stands at 4.23, while the sector’s is 3.48. In terms of returns, the stock offers a Dividend Yield of 0.03%, which is than the sector’s 0.57%.

Fredun Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Good

On its scorecard, Fredun Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost